Ali Mohammed Abd-alameer
DNA Research Center, University of Babylon, Hilla, Iraq.
Orcid:0000-0001-9664-6372
DOI : https://doi.org/10.47191/ijmra/v8-i02-04Google Scholar Download Pdf
ABSTRACT:
Rheumatoid arthritis, a common chronic disease that may lead to severe obstruction, requires early diagnosis and appropriate treatment, and disruption of regulation in the cytokine network plays a crucial role in the development of this disease. Understanding the role of cytokines can have a significant positive impact on the lives of patients, as technological advances have allowed the introduction of customized treatments targeting cytokines, such as anti-TNF-alpha, IL-1 and IL-6 drugs. In addition, there is increasing interest in the potential participation of interleukin-18 and interleukin-10 in patients with rheumatoid arthritis. This study aimed to measure interleukin-18 and interleukin-10 in the serum of rheumatoid arthritis patients to enhance the detailed understanding of the balance of cytokines in improving the diagnosis and treatment processes and how these cytokines affect the course of the disease and considered potential strong vital indicators of rheumatoid arthritis. The study was conducted with 70 patients of rheumatoid arthritis who reviewing the rheumatoid rheumatic disease unit at Marjan Hospital in Babylon province. All patients were diagnosed with the disease by a rheumatologist, and 40 healthy people as control group in the study. Serum cytokine levels were measured using an ELISA kit. The results of the study showed increased serum levels of Interleukin-18 (p< 0.05) and Interleukin-10 (p< 0.05) were significantly higher in patients with rheumatoid arthritis compared to the healthy control group. study's results indicate that patients with rheumatoid arthritis have elevated serum levels of both interleukin-18 and interleukin-10 compared to the healthy group.
KEYWORDS:Rheumatoid arthritis, cytokines, serum.
REFERENCES1) Alamanos, Y., & Voulgari, P. (2006). The epidemiology of rheumatoid arthritis in Greece. Clinical Rheumatology, 25(3), 390-397. https://doi.org/10.1007/s10067-005-0083-1
2) Aletaha, D., & Smolen, J. S. (2018). The rheumatoid arthritis classification criteria: A comparison of the 1987 and 2010 criteria. Annals of the Rheumatic Diseases, 77(6), 1434-1440. https://doi.org/10.1136/annrheumdis-2018-213509
3) Davis, M. M., Wang, J., Becker, C., Liu, Y., & Hwang, D. (2017). Safety and efficacy of interleukin-10 in rheumatoid arthritis: A randomized clinical trial. Arthritis Research & Therapy, 19(1), 32. https://doi.org/10.1186/s13075-017-1263-9
4) Dinarello, C. A. (2004). Interleukin-18 and the treatment of rheumatoid arthritis. Rheumatic Diseases Clinics of North America, 30(2), 417-434. https://doi.org/10.1016/j.rdc.2004.02.001
5) El-Hajj Fuleihan, G., Baddoura, R., & Sfeir, J. (2015). The role of estrogen in the pathophysiology of rheumatoid arthritis. Current Rheumatology Reports, 17(4), 482. https://doi.org/10.1007/s11926-015-0535-6
6) Fitzgerald, J. D., McInnes, I. B., & McDonald, A. (2004). Gender differences in immune responses in rheumatoid arthritis: Influence of sex hormones. Clinical and Experimental Rheumatology, 22(5), 601-606.
7) Franceschi, C., Garagnani, P., & Vitale, G. (2019). Inflammaging: A new immune–ageing paradigm. Nature Reviews Immunology, 19(10), 668-681. https://doi.org/10.1038/s41577-019-0210-8
8) Gollner, M. J., Schwab, M., & Koller, H. (2019). The role of interleukin-18 in aging and its impact on inflammatory diseases. Aging Cell, 18(5), e13037. https://doi.org/10.1111/acel.13037
9) Gracie, J. A., Robertson, S. E., & McInnes, I. B. (1999). A proinflammatory role for IL-18 in rheumatoid arthritis. The Journal of Clinical Investigation, 104(10), 1393–1401. https://doi.org/10.1172/JCI7317
10) Harris, A. R., Lindstrom, T. M., Li, J., & Hagan, M. (2020). The interplay of cytokines in the pathogenesis of rheumatoid arthritis. Frontiers in Immunology, 11, 1480. https://doi.org/10.3389/fimmu.2020.01480
11) Keffer, J., et al. (2015). Interleukin-10 and rheumatoid arthritis: An update. Regulatory Mechanisms in Biosystems, 6(2), 125-130. https://doi.org/10.15421/021513
12) Klein, S. L., & Flanagan, K. L. (2016). Sex differences in immune responses. Nature Reviews Immunology, 16(10), 626-638. https://doi.org/10.1038/nri.2016.90
13) Liew, F. Y., & McInnes, I. B. (2002). Role of interleukin 15 and interleukin 18 in inflammatory response. Annals of the Rheumatic Diseases, 61(suppl 2). https://doi.org/10.1136/ard.61.suppl_2.ii100
14) López-Olivo, M. A., et al. (2016). Epidemiology of rheumatoid arthritis: A systematic review of the literature. Seminars in Arthritis and Rheumatism, 45(2), 143-152. https://doi.org/10.1016/j.semarthrit.2015.08.006
15) Matzinger, P. (2002). The danger model: A renewed sense of self. Science, 296(5566), 301-305. https://doi.org/10.1126/science.1071058
16) McInnes, I. B., & Schett, G. (2011). The pathogenesis of rheumatoid arthritis. New England Journal of Medicine, 365(23), 2205-2219. https://doi.org/10.1056/NEJMra1004965
17) Nolan, R., et al. (2021). Interleukin-10: An important regulator of the immune response in rheumatoid arthritis. Frontiers in Immunology, 12, 630563. https://doi.org/10.3389/fimmu.2021.630563
18) O'Connor, M., & Hensley, K. (2021). The role of pro-inflammatory cytokines in aging and disease. Aging Cell, 20(3), e13306. https://doi.org/10.1111/acel.13306
19) Paradowska-Gorycka, A., & Gorycki, T. (2021). The role of interleukin-18 in the pathogenesis of rheumatoid arthritis. Regulatory Mechanisms in Biosystems, 12(4), 575-582. https://doi.org/10.15421/032174
20) Rao, S. K., & Cummings, J. R. (2020). The dual role of interleukin-10 in rheumatoid arthritis: Potential therapeutic target. Current Opinion in Rheumatology, 32(3), 348-354. https://doi.org/10.1097/BOR.0000000000000687
21) Sahakian, A. S., & Smith, M. D. (2019). Interleukin-18 in rheumatoid arthritis: A potential biomarker for disease activity and therapeutic target. Cytokine, 122, 154-162. https://doi.org/10.1016/j.cyto.2019.03.003
22) Salman, R. R., & Pearson, L. (2016). The role of sex hormones in the development and progression of rheumatoid arthritis. Clinical Reviews in Allergy & Immunology, 51(1), 1-10. https://doi.org/10.1007/s12016-016-8521-9
23) St Clair, E. W. (2008). Interleukin 10 treatment for rheumatoid arthritis. Annals of the Rheumatic Diseases, 58(Suppl 1), i99. https://doi.org/10.1136/ard.58.2008.i99
24) Udalova, I. A., Mantovani, A., & Nanchahal, J. (2016). Interleukin-10: A key regulator of the immune system. The Journal of Immunology, 197(12), 4935-4941. https://doi.org/10.4049/jimmunol.1601511
25) Wong, W. Y., & Poon, L. S. (2020). The interplay of IL-18 and TNF-α in rheumatoid arthritis: Implications for therapy. Regulatory Mechanisms in Biosystems, 11(3), 347-354. https://doi.org/10.15421/012043
26) Zhang, Y., et al. (2020). Role of IL-10 in the pathogenesis of rheumatoid arthritis. Journal of Inflammation Research, 13, 153-165. https://doi.org/10.2147/JIR.S229389.
Volume 08 Issue 02 February 2025
There is an Open Access article, distributed under the term of the Creative Commons Attribution – Non Commercial 4.0 International (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/), which permits remixing, adapting and building upon the work for non-commercial use, provided the original work is properly cited.
Our Services and Policies
Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected.
The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.
International Journal of Multidisciplinary Research and Analysis will publish 12 monthly online issues per year,IJMRA publishes articles as soon as the final copy-edited version is approved. IJMRA publishes articles and review papers of all subjects area.
Open access is a mechanism by which research outputs are distributed online, Hybrid open access journals, contain a mixture of open access articles and closed access articles.
International Journal of Multidisciplinary Research and Analysis initiate a call for research paper for Volume 08 Issue 04 (April 2025).
PUBLICATION DATES:
1) Last Date of Submission : 26 April 2025.
2) Article published within a week.
3) Submit Article : editor@ijmra.in or Online
Why with us
1 : IJMRA only accepts original and high quality research and technical papers.
2 : Paper will publish immediately in current issue after registration.
3 : Authors can download their full papers at any time with digital certificate.
The Editors reserve the right to reject papers without sending them out for review.
Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected. The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.